JERICHO SCIENCES Trademark

Trademark Overview


On Thursday, June 1, 2017, a trademark application was filed for JERICHO SCIENCES with the United States Patent and Trademark Office. The USPTO has given the JERICHO SCIENCES trademark a serial number of 87471983. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, January 30, 2018. This trademark is owned by Biovane, Inc.. The JERICHO SCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, IMMUNE DISORDERS; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, resp...
jericho sciences

General Information


Serial Number87471983
Word MarkJERICHO SCIENCES
Filing DateThursday, June 1, 2017
Status601 - ABANDONED - EXPRESS
Status DateTuesday, January 30, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, IMMUNE DISORDERS; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of MICROBIAL INFECTIONS; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for RETROVIRAL INFECTIONS; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for HUMAN THERAPEUTICS; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Medical diagnostic reagents for the analysis of body fluids; Syringes sold filled with HUMAN THERAPEUTICS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 8, 2017
Primary Code005
First Use Anywhere DateThursday, December 31, 2009
First Use In Commerce DateThursday, December 31, 2009

Trademark Owner History


Party NameBiovane, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGallatin, TN 37066

Trademark Events


Event DateEvent Description
Tuesday, January 30, 2018ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Tuesday, January 30, 2018ABANDONMENT - EXPRESS MAILED
Tuesday, January 30, 2018LETTER OF ABANDONMENT PROCESSED
Thursday, January 25, 2018ASSIGNED TO LIE
Wednesday, January 10, 2018PAPER RECEIVED
Wednesday, August 30, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2017NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 30, 2017ASSIGNED TO EXAMINER
Thursday, June 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 5, 2017NEW APPLICATION ENTERED IN TRAM